|
271 Companies |
|
374 Products |
|
374 Products |
|
160 Mechanisms of Action |
|
34 Trials |
|
5514 News |
|
| «12...7677787980818283848586...110111» |
- Pexa-Vec (pexastimogene devacirepvec) / SillaJen, Transgene
New P2 trial, P2 data: Phase 2 Study of JX-594 in Patients With Peritoneal Carcinomatosis of Ovarian Cancer Origin (clinicaltrials.gov) - Dec 19, 2013
P2, N=25, Not yet recruiting, Sponsor: Andrea McCart
- |||||| Enrollment open, Preclinical: Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF (clinicaltrials.gov) - Dec 18, 2013
P3, N=1106, Recruiting, Sponsor: Finox AG
Not yet recruiting --> Recruiting
- Enrollment closed: IVF Clinical Trial of Two Different Treatment Protocols. (clinicaltrials.gov) - Dec 18, 2013
P=N/A, N=564, Active, not recruiting, Sponsor: New Hope Fertility Center
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting
- Avastin (bevacizumab) / Roche
Trial withdrawal: Safety and Efficacy Study of Gemcitabine Plus Bevacizumab in Patients With Platinum-Resistant Ovarian, Primary Peritoneal or Fallopian Tube Cancer (clinicaltrials.gov) - Dec 18, 2013
P2, N=0, Withdrawn, Sponsor: Emory University
Recruiting --> Active, not recruiting Recruiting --> Withdrawn
- Trial suspension: Image-guided Adaptive Radiotherapy for Cervix Cancer: Patient Image Acquisition (clinicaltrials.gov) - Dec 18, 2013
P=N/A, N=25, Suspended, Sponsor: Virginia Commonwealth University
Recruiting --> Withdrawn Recruiting --> Suspended
- Avastin (bevacizumab) / Roche
Enrollment change: Safety and Efficacy Study of Gemcitabine Plus Bevacizumab in Patients With Platinum-Resistant Ovarian, Primary Peritoneal or Fallopian Tube Cancer (clinicaltrials.gov) - Dec 18, 2013
P2, N=0, Withdrawn, Sponsor: Emory University
Recruiting --> Suspended N=37 --> 0
- New P2 trial: Effect of Curcumin Addition to Standard Treatment on Tumour-induced Inflammation in Endometrial Carcinoma (clinicaltrials.gov) - Dec 18, 2013
P2, N=10, Recruiting, Sponsor: University Hospital, Gasthuisberg
- | Vivelle (estradiol transdermal system) / Sanofi, Hisamitsu, Novartis, Estreva oral (estradiol oral) / EMD Serono, Estrace (estradiol) / AbbVie
Trial completion: Estrogen Dosing in Turner Syndrome: Pharmacology and Metabolism (clinicaltrials.gov) - Dec 18, 2013
P4, N=41, Completed, Sponsor: Nemours Children's Clinic
N=37 --> 0 Active, not recruiting --> Completed
- |||||||||| Baxdela (delafloxacin) / Menarini, Melinta Therap
New P3 trial: Comparison of Delafloxacin Versus Ceftriaxone for the Treatment of Uncomplicated Gonorrhea (clinicaltrials.gov) - Dec 17, 2013
P3, N=757, Recruiting, Sponsor: Melinta Therapeutics, Inc.
- | IDC-G305 / Merck (MSD)
New P1 trial, Metastases: A Phase 1 Trial of NY-ESO-1 With GLA-SE in Patients With Unresectable or Metastatic Cancer (clinicaltrials.gov) - Dec 17, 2013
P1, N=30, Recruiting, Sponsor: Immune Design
- IDC-G305 / Merck (MSD)
Enrollment open, Metastases: A Phase 1 Trial of NY-ESO-1 With GLA-SE in Patients With Unresectable or Metastatic Cancer (clinicaltrials.gov) - Dec 17, 2013
P1, N=30, Recruiting, Sponsor: Immune Design
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- | carboplatin / Generic mfg., paclitaxel / Generic mfg., docetaxel / Generic mfg.
Trial completion: Carboplatin Plus Paclitaxel or Docetaxel in Treating Patients With Ovarian Epithelial Cancer (clinicaltrials.gov) - Dec 17, 2013
P3, N=1050, Completed, Sponsor: University of Glasgow
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- New P4 trial: Oral Low-molecular Weight Hyaluronic Acid in the Treatment of Atrophic Vaginitis (clinicaltrials.gov) - Dec 16, 2013
P4, N=0, Completed, Sponsor: AGUNCO Obstetrics and Gynecology Centre
- medroxyprogesterone injection / Generic mfg.
Trial completion: DMPA & High Dose Oral Progestin (MPA) Tablets in Outpatient Treatment of Acute Excessive Vaginal Bleeding (clinicaltrials.gov) - Dec 16, 2013
P4, N=48, Completed, Sponsor: Women's Health Care Clinic, Torrance, California
Active, not recruiting --> Completed Recruiting --> Completed
- epacadostat (INCB024360) / Incyte
Trial withdrawal, Combination therapy: Vaccine Therapy and IDO1 Inhibitor INCB024360 in Treating Patients With Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Are in Remission (clinicaltrials.gov) - Dec 16, 2013
P1/2, N=0, Withdrawn, Sponsor: Roswell Park Cancer Institute
Recruiting --> Completed Not yet recruiting --> Withdrawn
- epacadostat (INCB024360) / Incyte
Enrollment change, Combination therapy: Vaccine Therapy and IDO1 Inhibitor INCB024360 in Treating Patients With Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Are in Remission (clinicaltrials.gov) - Dec 16, 2013
P1/2, N=0, Withdrawn, Sponsor: Roswell Park Cancer Institute
Not yet recruiting --> Withdrawn N=92 --> 0
- | Korlym (mifepristone) / Corcept Therap
New P1 trial, Combination therapy, Metastases: Mifepristone and Eribulin in Patients With Metastatic Triple Negative Breast Cancer or Other Specified Solid Tumors (clinicaltrials.gov) - Dec 16, 2013
P1, N=40, Recruiting, Sponsor: Corcept Therapeutics
- | Trial completion, Surgery: Surgery With or Without Lymphadenectomy and Radiation Therapy in Treating Patients With Endometrial Cancer (clinicaltrials.gov) - Dec 16, 2013
P3, N=2300, Completed, Sponsor: Medical Research Council
N=92 --> 0 Active, not recruiting --> Completed
- Enrollment open: Hysteroscopic Assessment of Fallopian Tubal Patency (clinicaltrials.gov) - Dec 15, 2013
P=N/A, N=500, Recruiting, Sponsor: University of Mississippi Medical Center
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- Enrollment open: Polycystic Ovary Syndrome - Improving Outcomes (clinicaltrials.gov) - Dec 15, 2013
P4, N=42, Recruiting, Sponsor: Baker IDI Heart and Diabetes Institute
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- Orgalutran (ganirelix acetate) / Organon, Follistim AQ Cartridge (follitropin beta) / Organon
Trial initiation date: Modified Natural Cycle Offers a Chance of Pregnancy in Patients With Poor Response and High Basal FSH (clinicaltrials.gov) - Dec 12, 2013
P4, N=135, Completed, Sponsor: Eugonia
Not yet recruiting --> Recruiting Initiation date: Oct 2003 --> Jan 2007
- Orgalutran (ganirelix acetate) / Organon, Follistim AQ Cartridge (follitropin beta) / Organon
Enrollment change: Modified Natural Cycle Offers a Chance of Pregnancy in Patients With Poor Response and High Basal FSH (clinicaltrials.gov) - Dec 12, 2013
P4, N=135, Completed, Sponsor: Eugonia
Initiation date: Oct 2003 --> Jan 2007 N=48 --> 135
- Orgalutran (ganirelix acetate) / Organon, Follistim AQ Cartridge (follitropin beta) / Organon
Trial completion: Modified Natural Cycle Offers a Chance of Pregnancy in Patients With Poor Response and High Basal FSH (clinicaltrials.gov) - Dec 12, 2013
P4, N=135, Completed, Sponsor: Eugonia
N=48 --> 135 Active, not recruiting --> Completed
- Trial completion: HIV Prevention Program for African American Teen Males (clinicaltrials.gov) - Dec 12, 2013
P=N/A, N=840, Completed, Sponsor: University of Kentucky
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Erbitux (cetuximab) / Eli Lilly, EMD Serono
Trial completion, Metastases: Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer (clinicaltrials.gov) - Dec 11, 2013
P1, N=100, Completed, Sponsor: Gynecologic Oncology Group
Active, not recruiting --> Completed Active, not recruiting --> Completed
- dexamethasone injection / Generic mfg.
Trial termination, Surgery: Peritoneal Cavity Conditioning Decreases Pain, Inflammation and Adhesions (clinicaltrials.gov) - Dec 10, 2013
P=N/A, N=22, Terminated, Sponsor: University Hospital, Gasthuisberg
Active, not recruiting --> Completed Recruiting --> Terminated; Investigator no longer works fulltime at investigational site
- Zyclara (imiquimod) / Mochida, Viatris, Bausch Health
Biomarker, Enrollment change: Identification of Novel Biomarkers of Cervicovaginal Mucosal Inflammation (clinicaltrials.gov) - Dec 10, 2013
P2, N=39, Completed, Sponsor: CONRAD
Recruiting --> Terminated; Investigator no longer works fulltime at investigational site N=30 --> 39
- dexamethasone injection / Generic mfg.
Enrollment change, Surgery: Peritoneal Cavity Conditioning Decreases Pain, Inflammation and Adhesions (clinicaltrials.gov) - Dec 10, 2013
P=N/A, N=22, Terminated, Sponsor: University Hospital, Gasthuisberg
N=30 --> 39 N=40 --> 22
- azithromycin / Generic mfg.
Enrollment change: Effectiveness of HIV/Sexually Transmitted Infection Training for Physicians in China (clinicaltrials.gov) - Dec 10, 2013
P=N/A, N=1373, Completed, Sponsor: University of California, Los Angeles
N=40 --> 22 N=2640 --> 1373
- | veliparib (ABT-888) / AbbVie
New P1 trial: A Study to Evaluate the Effects of Veliparib on Heart Rhythms in Patients With Solid Tumors (clinicaltrials.gov) - Dec 10, 2013
P1, N=42, Recruiting, Sponsor: AbbVie
- Zyclara (imiquimod) / Mochida, Viatris, Bausch Health
Biomarker, Trial completion: Identification of Novel Biomarkers of Cervicovaginal Mucosal Inflammation (clinicaltrials.gov) - Dec 10, 2013
P2, N=39, Completed, Sponsor: CONRAD
N=2640 --> 1373 Active, not recruiting --> Completed
- Trial completion: Effectiveness of Community-Level Behavioral and Biomedical Interventions for Reducing HIV/STIs in Men in Peru (clinicaltrials.gov) - Dec 10, 2013
P=N/A, N=718, Completed, Sponsor: University of California, Los Angeles
Active, not recruiting --> Completed Recruiting --> Completed
- azithromycin / Generic mfg.
Trial completion: Effectiveness of HIV/Sexually Transmitted Infection Training for Physicians in China (clinicaltrials.gov) - Dec 10, 2013
P=N/A, N=1373, Completed, Sponsor: University of California, Los Angeles
Recruiting --> Completed Recruiting --> Completed
- | New P2 trial: Salpingectomy Versus Aspiration of Hydrosalpingeal Fluid Prior to IVF-ET (clinicaltrials.gov) - Dec 9, 2013
P2, N=140, Recruiting, Sponsor: Aljazeera Hospital
- Clinical: Randomized Evaluation of a Multi-Component, Rights-Based Sexuality Education Initiative for High School Students (clinicaltrials.gov) - Dec 9, 2013
P=N/A, N=2379, Active, not recruiting, Sponsor: Public Health Institute, California
- Preclinical, Trial termination: The Luveris In Vitro Fertilization Trial (clinicaltrials.gov) - Dec 8, 2013
P4, N=14, Terminated, Sponsor: University Reproductive Associates
Recruiting --> Completed Active, not recruiting --> Terminated; Drug no longer available by manufacturer
- || Preclinical, Enrollment change: Follicle Stimulating Hormone (FSH) Receptor Polymorphisms in In-Vitro Fertilization Cycles. (clinicaltrials.gov) - Dec 8, 2013
P=N/A, N=75, Completed, Sponsor: University Reproductive Associates
Active, not recruiting --> Terminated; Drug no longer available by manufacturer N=100 --> 75
- Preclinical, Enrollment change: The Luveris In Vitro Fertilization Trial (clinicaltrials.gov) - Dec 8, 2013
P4, N=14, Terminated, Sponsor: University Reproductive Associates
N=100 --> 75 N=30 --> 14
- Surgery: Beneficial Effects of Microsurgical Varicocelectomy on Semen Parameters for Causes Other Than Infertility (clinicaltrials.gov) - Dec 8, 2013
P=N/A, N=121, Completed, Sponsor: Seoul National University Hospital
- ethinyl estradiol/levonorgestrel / Generic mfg.
Enrollment open: Treatment of Unacceptable Bleeding Patterns in ETG Implant Users With an Oral Contraceptive (clinicaltrials.gov) - Dec 8, 2013
P4, N=130, Recruiting, Sponsor: University of California, Davis
N=30 --> 14 Not yet recruiting --> Recruiting
- Enrollment open: FertilEX: Improved Fertility After Exercise in Overweight/Obese Women (clinicaltrials.gov) - Dec 8, 2013
P=N/A, N=370, Recruiting, Sponsor: Norwegian University of Science and Technology
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- Estrace topical (estradiol) / AbbVie, Estrace (estradiol) / AbbVie
Enrollment closed: Effects of Androgen Blockade on Sensitivity of the GnRH Pulse Generator to Suppression by Estradiol and Progesterone (clinicaltrials.gov) - Dec 8, 2013
P=N/A, N=13, Active, not recruiting, Sponsor: University of Virginia
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting
- Trial completion, Preclinical: In Vitro Maturation (IVM) for Polycystic Ovary Syndrome (PCOS) (clinicaltrials.gov) - Dec 8, 2013
P=N/A, N=10, Completed, Sponsor: University Reproductive Associates
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- ||| Trial completion, Preclinical: Follicle Stimulating Hormone (FSH) Receptor Polymorphisms in In-Vitro Fertilization Cycles. (clinicaltrials.gov) - Dec 8, 2013
P=N/A, N=75, Completed, Sponsor: University Reproductive Associates
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Trial withdrawal: Post Operative Continuous Active Combination Sex Steroids for the Prevention of Recurrent Endometrioma Formation (clinicaltrials.gov) - Dec 8, 2013
P=N/A, N=0, Withdrawn, Sponsor: University of Oklahoma
Active, not recruiting --> Completed Terminated --> Withdrawn
- ||||| trebananib (AMG 386) / Amgen
Enrollment change: AMG 386 (Trebananib) in Ovarian Cancer (TRINOVA-2) (clinicaltrials.gov) - Dec 4, 2013
P3, N=223, Active, not recruiting, Sponsor: Amgen
Terminated --> Withdrawn N=380 --> 223
- ||||| Perjeta (pertuzumab) / Roche
New P2 trial, Combination therapy: A Study to Evaluate the Effect of the Combination of Pertuzumab With Carboplatin-Based Standard Chemotherapy in Patients With Recurrent Ovarian Cancer (clinicaltrials.gov) - Dec 4, 2013
P2, N=152, Completed, Sponsor: Hoffmann-La Roche
- ||||| trebananib (AMG 386) / Amgen
Enrollment closed: AMG 386 (Trebananib) in Ovarian Cancer (TRINOVA-2) (clinicaltrials.gov) - Dec 4, 2013
P3, N=223, Active, not recruiting, Sponsor: Amgen
N=380 --> 223 Recruiting --> Active, not recruiting
- ||| Visanne (dienogest) / Mochida, Bayer
Enrollment closed: VISADO: Visanne Study to Assess Safety in Adolescents (clinicaltrials.gov) - Dec 3, 2013
P2, N=111, Active, not recruiting, Sponsor: Bayer
Recruiting --> Active, not recruiting Completed --> Active, not recruiting
- Biomarker, Trial completion: Use of Dehydroepiandrosterone (DHEA) in Women With Normal and Poor Ovarian Reserve Undergoing IVF (clinicaltrials.gov) - Dec 3, 2013
P=N/A, N=104, Completed, Sponsor: The University of Hong Kong
Completed --> Active, not recruiting Active, not recruiting --> Completed